CEDNEVY
Live / Applied — Third extension granted (statement of use) (as of 10 Feb 2026)
What this means for you
Not registered yet, but its 28 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98287445
- Mark type
- Design + words
- Filed
- 28 Nov 2023
- Published for opposition
- 02 Jul 2024
- Attorney of record
- A. Tally Eitan
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of parkinsons disease
Owner
- Mitsubishi Tanabe Pharma Corporation, Chuo-ku, Osaka-shi Osa, JP
- Mitsubishi Tanabe Pharma Corporation, Chuo-ku, Osaka-shi Osa, JP
Prosecution history
- 10 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Feb 2026 — SOU EXTENSION 3 GRANTED
- 10 Feb 2026 — SOU EXTENSION 3 FILED
- 10 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Jul 2025 — SOU EXTENSION 2 GRANTED
- 10 Jul 2025 — SOU EXTENSION 2 FILED
- 10 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 16 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Feb 2025 — SOU EXTENSION 1 GRANTED
- 16 Feb 2025 — SOU EXTENSION 1 FILED
- 16 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Jul 2024 — PUBLISHED FOR OPPOSITION